Clinical Trial Update: Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assesses the immunogenicity of an inactivated EV71 vaccine combined with hepatitis B and group A meningococcal vaccines for hand, foot …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (inactivated) combined with Hepatitis B vaccine and group A meningococcal vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: UNKNOWN